Skip Navigation LinksHome > November 2009 - Volume 31 - Issue 11 > Severe Ceftriaxone-induced Hemolysis Complicated by Diffuse...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e3181b7eda2
Clinical and Laboratory Observations

Severe Ceftriaxone-induced Hemolysis Complicated by Diffuse Cerebral Ischemia in a Child With Sickle Cell Disease

Schuettpelz, Laura G. MD, PhD*; Behrens, Deanna MD; Goldsmith, Matthew I. MD; Druley, Todd E. MD, PhD*

Collapse Box


Ceftriaxone-induced hemolytic anemia is a rare and often fatal phenomenon. We report here the case of a 6-year-old female with sickle cell disease who survived a brisk and profound hemolytic reaction, resulting in hemoglobin of 0.4 g/dL, after ceftriaxone infusion. Ongoing hemolysis was abrogated with aggressive supportive care, but the patient suffered extensive neurologic sequelae as a result of the event. Serologic testing confirmed the presence of ceftriaxone antibodies.

© 2009 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.